Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease is a research paper published in Journal of the American College of Cardiology (2023). On theSindex it has a DataRank of 1.3. It has been cited 47 times, with 34 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.581
From this paper's citation signal
Citation Network Contribution
0.712
From 20 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 34 citers.
NHLBI NIH HHS
Grant: UG1 HL135646
NHLBI NIH HHS
Grant: UG1 HL135683
NHLBI NIH HHS
Grant: UG1 HL135678
NHLBI NIH HHS
Grant: UG1 HL135689
NHLBI NIH HHS
Grant: UG1 HL135665
NHLBI NIH HHS
Grant: UG1 HL135680
NHLBI NIH HHS
Grant: U24 HL135691
NHLBI NIH HHS
Grant: UG1 HL135666
NHLBI NIH HHS
Grant: UG1 HL135685
NHLBI NIH HHS
Grant: UG1 HL135682
NHLBI
Bristol-Myers Squibb Company
FWCI
8.88
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals